Elena Élez

机构：Vall d'Hebron Hospital Universitari, CIBBIM-Nanomedicine, Vall d'Hebron Institute of Oncology · ORCID：0000-0002-9178-0246

发表论文 62 篇 · 总被引 2686 次 · h-index 20

代表论文

• Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer (2024 · New England Journal of Medicine · 被引 246)
• Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial (2025 · The Lancet · 被引 216)
• Encorafenib, Cetuximab, and mFOLFOX6 in BRAF -Mutated Colorectal Cancer (2025 · New England Journal of Medicine · 被引 125)
• Five latent factors underlie response to immunotherapy (2024 · Nature Genetics · 被引 34)
• A CT-based deep learning-driven tool for automatic liver tumor detection and delineation in patients with cancer (2025 · Cell Reports Medicine · 被引 22)
• EORTC consensus recommendations on the optimal management of colorectal cancer liver metastases (2025 · Cancer Treatment Reviews · 被引 20)